18th April 2026
MIP vaccine for leprosy is important to protect close contacts and reduce spread of the disease.
Leprosy is a chronic infectious disease that affects the skin and nerves. Leprosy spreads very slowly and mainly affects people who have long-term, close contact with an untreated patient. The good news is — it is curable, and simple measures like early treatment and vaccination of contacts can help stop its spread.
This article explains the MIP vaccine in simple terms. Additionally, the article highlights the role, benefits, and safety of the MIP vaccine.
WHAT IS MIP VACCINE?
The MIP (Mycobacterium Indicus Pranii) vaccine is an immune-boosting vaccine.
It helps the body fight the bacteria that causes leprosy.
It does not replace standard treatment, but supports prevention
WHAT IS LEPROSY?
Leprosy is an infectious disease. Mycobacterium leprae causes it and primarily affects the skin and peripheral nerves.
Common signs include:
- Light or reddish skin patches
- Reduced sensation
- Lack of sweating or hair in affected areas
HOW DOES LEPROSY SPREAD?
Leprosy spreads very slowly
It requires long-term, close contact (months to years)
It does not spread through casual contact like handshakes or sharing food
Important: Once a patient starts treatment, the disease becomes almost non-infectious, with more than 95% reduction in transmission.
WHO SHOULD TAKE MIP VACCINE?
Doctors generally recommend the MIP vaccine for:
- Individuals diagnosed with leprosy
- Close contacts such as family members and neighbours
DOSING SCHEDULE
- Typically given in 2–3 doses
- Spaced about 6 months apart
BENEFITS OF MIP VACCINE FOR LEPROSY
- Boosts immune response against leprosy
- Helps protect close contacts
- Indian studies have shown around 60–70% protection in contacts
IS MIP VACCINE SAFE?
Doctors consider the MIP vaccine safe and well-tolerated in most individuals.
Mild side effects may include:
- Pain at injection site
- Redness or swelling
These effects usually settle within 2-4 weeks
WHAT SHOULD YOU DO IF SOMEONE IN FAMILY HAS LEPROSY?
Do not panic
Get screening done by nearest dermatologist or govt hospital.
Start treatment early
Ask doctor about MIP vaccine for contacts
WHERE IS THE VACCINE GIVEN?
Healthcare workers administer the vaccine intradermally in the upper arm.
CONCLUSION
The MIP vaccine is a useful tool in controlling leprosy, particularly among close contacts. Awareness, early detection, and appropriate treatment remain key in reducing disease burden.
ONGOING WORK IN INDIA
A large ICMR-supported implementation project is ongoing in Delhi and Haryana .
The research team is conducting the study at Amrita Hospital Faridabad. Dr. Neena Khanna leads the study, along with team member Dr. Sachin Gupta.
The aim is to evaluate how MIP vaccination can help reduce new cases in real-world settings
Learn more
National Leprosy Eradication Programme (India)
Indian MIP Vaccine Study (Kanpur trial)
Recent research on MIP vaccine in tuberculosis (Dr. Manjul et al.)
For more skin health awareness and expert advice, read the articles below:
Understanding and Treating Acne Scars: Expert Insights in Dermatology
Why Popping Pimples Is Harmful: Advice from a Dermatologist
High SPF Sunscreens: Health Risks and Benefits
DISCLAIMER
This article is for general educational purposes only and does not replace professional medical advice.
AUTHOR
Dr. Sachin Gupta
Assist Professor, Amrita Hospital
MBBS, MD Dermatology (AIIMS Delhi)